Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial ...
来自MSN3 分钟
What Is Amla Oil?
Before taking amla oil or any new therapy, ask your healthcare provider what supplement and dosage may ... However, some ...
2024 — More than two-thirds of people taking blood thinners take direct oral anticoagulants, or DOACs, which are under- or over-prescribed in up to one in eight patients. A new study finds that most ...
The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...
AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.
Striking New Moray Eel Discovered in Central Indo-Pacific River Mouths, Named After God of the Underworld Dec. 30, 2024 — A new species of black, slender moray eel has chosen the road less ...
Karen L. Hassenplug, Pharm.D.; Jill S. Burkiewicz, Pharm.D., BCPS; Terri L. Jackson, Ph.D., B.S.Pharm.; Laura R. Peppers, Pharm.D., BCPS Identifying baseline ...
The integration of several new 'omics' techniques enables a multifaceted ... that can also be the possible future target of new anticoagulant and thrombolytic therapies for more personalized ...
The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.
What are the best new MMOs? Once as rare as a legendary loot drop, new MMOs seem to be launching every other month these days. MMOs offer near-boundless freedom in a world populated by a vast ...
One of the most commonly used types of medication to prevent strokes is blood thinners. These medications reduce the risk of ...
By Cindi Leive Grady Hendrix’s new novel, “Witchcraft for Wayward Girls,” is a timely look at the mistreatment of women, with a dose of horror, monsters and magic. By Hugh Ryan A powerful ...